Fosigotifator

DB19409InvestigationalSmall molecule

Fosigotifator is under investigation in clinical trial NCT05757141 (An Open-label Exploratory Study of ABBV-CLS-7262 Subjects With Vanishing White Matter Disease).

Chemical structure of Fosigotifator
Formula / weight
C25H27Cl2F2N2O9P · 639.37 g/mol (avg)
Also known as
Sodium ({(2S)-1,4-bis[2-(4-chloro-3- fluorophenoxy)acetamido]bicyclo[2.2.2]octan-2- yl}oxy)methyl hydrogen phosphate - 2-amino-2- (hydroxymethyl)propane-1,3-diol (1/1/1)
Code names
ABBV-CLS-7262 · CS-0716568 · DA-63590 · HY-153399

Resolves to

Compound
UNII3FQ7XKK8AYCAS2415715-84-1ChEMBLCHEMBL5315045
Structure
InChIKeyIURMHIZNAHLQRX-ANYOXOOPSA-NSMILESOP(O)(=O)OCO[C@H]1CC2(CCC1(CC2)NC(=O)COC1=CC=C(Cl)C(F)=C1)NC(=O)COC1=CC=C(Cl)C(F)=C1

What you can answer from here — as of September 07, 2026

11Clinical trialsPhase, status and sponsor resolved per trial
Sign in

Which companies are running trials of Fosigotifator, in which indications and phases, and which of those programs are still active?

Answer this in Biopharma OSSign in to your account

Create a free account or log in to explore the full data card.

Create Account
Log InPaid Account Log In